View More View Less
  • 1 Semmelweis University Department of Medical Microbiology Budapest Hungary
  • | 2 Semmelweis University Graduate medical student Budapest Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

The predominant causative agent of urinary tract infections in children and adults is Escherichia coli , but it is necessary to appreciate the importance of other Gram-negative rods, especially in newborns. Antibiotic resistance rates are also different in children and in adult care units due to many factors and therapeutical guidelines.The aim of this retrospective study was to show the local prevalence and resistance patterns of uropathogens in certain clinics of university and present the distribution of uropathogens in different age groups. Therefore, 4833 positive samples were analysed. E. coli was found to be the highest prevalent causative agent in every adult care unit, but some differences in other causative agents could have been detected. Three types of antimicrobial agents showed decreasing susceptibility rates: trimethoprim/sulfamethoxasole, cephalosporins and quinolones; but there were differences in resistance among the 8 investigated inpatient wards.

  • Joshi, S. G., Litake, G. M., Niphadkar, K. B., Ghole, V. S.: Multidrug resistant Acinetobacter baumannii isolates from a teaching hospital. J. Infect. Chemother. 9(2) , 187–190 (2003).

    Ghole V. S. , 'Multidrug resistant Acinetobacter baumannii isolates from a teaching hospital ' (2003 ) 9 J. Infect. Chemother. : 187 -190.

    • Search Google Scholar
  • Bean, D. C., Krahe, D., Wareham, D. W.: Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005–2006. Annals of Clinical Microbiology and Antimicrobials 7 , 13 (2008).

    Wareham D. W. , 'Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005–2006 ' (2008 ) 7 Annals of Clinical Microbiology and Antimicrobials : 13 -.

    • Search Google Scholar
  • Tenke, P., Ludwig, E., Kovács, B.: A nem komplikált húgyúti fertõzések diagnosztikája és kezelése a bizonyítékok tükrében. Infektológia és Klinikai Mikrobiológia 3–4 , 39–50 (2007).

    Kovács B. , 'A nem komplikált húgyúti fertõzések diagnosztikája és kezelése a bizonyítékok tükrében ' (2007 ) 3–4 Infektológia és Klinikai Mikrobiológia : 39 -50.

    • Search Google Scholar
  • Conway, P. H., Cnaan, A., Zaoutis, T., Henry, B. V., Grundmeier, R. W., Keren, R.: Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. Jama 298(2) , 179–186 (2007).

    Keren R. , 'Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials ' (2007 ) 298 Jama : 179 -186.

    • Search Google Scholar
  • Prelog, M., Schiefecker, D., Fille, M., Wurzner, R., Brunner, A., Zimmerhackl, L. B.: Febrile urinary tract infection in children: ampicillin and trimethoprim insufficient as empirical mono-therapy. Pediatric Nephrology (Berlin, Germany) 23(4) , 597–602 (2008).

    Zimmerhackl L. B. , 'Febrile urinary tract infection in children: ampicillin and trimethoprim insufficient as empirical mono-therapy ' (2008 ) 23 Pediatric Nephrology (Berlin, Germany) : 597 -602.

    • Search Google Scholar
  • Zorc, J. J., Kiddoo, D. A., Shaw, K. N.: Diagnosis and management of pediatric urinary tract infections. Clinical Microbiology Reviews 18(2) , 417–422 (2005).

    Shaw K. N. , 'Diagnosis and management of pediatric urinary tract infections ' (2005 ) 18 Clinical Microbiology Reviews : 417 -422.

    • Search Google Scholar
  • Bronsema, D. A., Adams, J. R., Pallares, R., Wenzel, R. P.: Secular trends in rates and etiology of nosocomial urinary tract infections at a university hospital. J. Urol. 150 , 414–416 (1993).

    Wenzel R. P. , 'Secular trends in rates and etiology of nosocomial urinary tract infections at a university hospital ' (1993 ) 150 J. Urol. : 414 -416.

    • Search Google Scholar
  • Malani, A. N., Kauffman, C. A.: Candida urinary tract infections: treatment options. Expert Rev. Anti Infect. Ther. 5(2) , 277–284 (2007).

    Kauffman C. A. , 'Candida urinary tract infections: treatment options ' (2007 ) 5 Expert Rev. Anti Infect. Ther. : 277 -284.

    • Search Google Scholar
  • Tolkoff-Rubin, N. E., Conti, D. J., Doran, M., DelVecchio, A., Rubin, R. H.: Fluconazole in the treatment of invasive candidal and cryptococcal infections in organ transplant recipients. Pharmacotherapy 10 , 159S–163S (1990).

    Rubin R. H. , 'Fluconazole in the treatment of invasive candidal and cryptococcal infections in organ transplant recipients ' (1990 ) 10 Pharmacotherapy : 159S -163S.

    • Search Google Scholar
  • Baerheim, A.: Empirical treatment of uncomplicated cystitis. BMJ (Clinical Researched) 323(7323) , 1197–1198 (2001).

    Baerheim A. , 'Empirical treatment of uncomplicated cystitis ' (2001 ) 323 BMJ (Clinical Researched) : 1197 -1198.

    • Search Google Scholar
  • Bean, D. C., Livermore, D. M., Papa, I., Hall, L. M.: Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man. JAC 56 , 962–964 (2005).

    Hall L. M. , 'Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man ' (2005 ) 56 JAC : 962 -964.

    • Search Google Scholar
  • Nosocomial enterococci resistant to vancomycin — United States, 1989–1993. Mmwr 42(30) , 597–599 (1993).

  • Loeb, M., Salama, S., Armstrong-Evans, M., Capretta, G., Olde, J.: A case-control study to detect modifiable risk factors for colonization with vancomycin-resistant enterococci. Infect Control Hosp. Epidemiol. 20(11) , 760–763 (1999).

    Olde J. , 'A case-control study to detect modifiable risk factors for colonization with vancomycin-resistant enterococci ' (1999 ) 2011 Infect Control Hosp. Epidemiol. : 760 -763.

    • Search Google Scholar
  • Corti, G., Giganti, E., Paradisi, F., Nicoletti, P.: Urinary tract infections in the city of Florence: epidemiological considerations over a twenty-year period. Eur. J. Epidemiol. 9 , 335–340 (1993).

    Nicoletti P. , 'Urinary tract infections in the city of Florence: epidemiological considerations over a twenty-year period ' (1993 ) 9 Eur. J. Epidemiol. : 335 -340.

    • Search Google Scholar
  • Esposito, S., Noviello, S., Leone, S.: Catheter-associated urinary tract infections: epidemiology and prevention. Infez. Med. 16(3) , 130–143 (2008).

    Leone S. , 'Catheter-associated urinary tract infections: epidemiology and prevention ' (2008 ) 16 Infez. Med. : 130 -143.

    • Search Google Scholar
  • Naber, K. G., Bergman, B., Bishop, M. C., Bjerklund-Johansen, T. E., Botto, H., Lobel, B., Jinenez Cruz, F., Selvaggi, F. P.: EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). European Urology 40(5) , 576–588 (2001).

    Selvaggi F. P. , 'EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU) ' (2001 ) 40 European Urology : 576 -588.

    • Search Google Scholar
  • Reddy, P. P., Evans, M. T., Hughes, P. A., Dangman, B., Cooper, J., Lepow, M. L., Calvano, C. J., Mandell, J.: Antimicrobial prophylaxis in children with vesico-ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance. Pediatrics 100 , 555–556 (1997).

    Mandell J. , 'Antimicrobial prophylaxis in children with vesico-ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance ' (1997 ) 100 Pediatrics : 555 -556.

    • Search Google Scholar
  • Beier, M. T.: Management of urinary tract infections in the nursing home elderly: a proposed algorithmic approach. International Journal of Antimicrobial Agents 11(3–4) , 275–284 (1999).

    Beier M. T. , 'Management of urinary tract infections in the nursing home elderly: a proposed algorithmic approach ' (1999 ) 11 International Journal of Antimicrobial Agents : 275 -284.

    • Search Google Scholar
  • Chou, Y. Y., Lin, T. Y., Lin, J. C., Wang, N. C., Peng, M. Y., Chang, F. Y.: Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis . Journal of Microbiology, Immunology, and Infection = Wei mian yu gan ran za zhi 41(2) , 124–129 (2008).

    Chang F. Y. , 'Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis ' (2008 ) 41 Journal of Microbiology, Immunology, and Infection = Wei mian yu gan ran za zhi : 124 -129.

    • Search Google Scholar
  • Wazait, H. D., Patel, H. R., Veer, V., Kelsey, M., Van Der Meulen, J. H., Miller, R. A., Emberton, M.: Catheter-associated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996–2001). BJU International 91(9) , 806–809 (2003).

    Emberton M. , 'Catheter-associated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996–2001) ' (2003 ) 91 BJU International : 806 -809.

    • Search Google Scholar
  • Ko, M. C., Liu, C. K., Woung, L. C., Lee, W. K., Jeng, H. S., Lu, S. H., Chiang, H. S., Li, C. Y.: Species and antimicrobial resistance of uropathogens isolated from patients with urinary catheter. The Tohoku Journal of Experimental Medicine 214(4) , 311–319 (2008).

    Li C. Y. , 'Species and antimicrobial resistance of uropathogens isolated from patients with urinary catheter ' (2008 ) 214 The Tohoku Journal of Experimental Medicine : 311 -319.

    • Search Google Scholar
  • Manges, A. R., Tabor, H., Tellis, P., Vincent, C., Tellier, P. P.: Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerging Infectious Diseases 14(10) , 1575–1583 (2008).

    Tellier P. P. , 'Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections ' (2008 ) 14 Emerging Infectious Diseases : 1575 -1583.

    • Search Google Scholar
  • Szabó, D.: Importance of extended-spectrum betalactamase production. (Possibility of detection and epidemiology). Infectology and Clinical Microbiology 3 , 90–99 (2003).

    Szabó D. , 'Importance of extended-spectrum betalactamase production. (Possibility of detection and epidemiology) ' (2003 ) 3 Infectology and Clinical Microbiology : 90 -99.

    • Search Google Scholar
  • Antibiotic susceptibility of Escherichia coli . NNSR Annual Report 2007, www.oek.hu

  • Santo, E., Mendonca, M., Martin, S., Martin, J. M.: Multidrug-resistant urinary tract isolates of Escherichia coli from Ribeirao Preto, Sao Paulo, Brazil. BJID 11(6) , 575–578 (2007).

    Martin J. M. , 'Multidrug-resistant urinary tract isolates of Escherichia coli from Ribeirao Preto, Sao Paulo, Brazil ' (2007 ) 11 BJID : 575 -578.

    • Search Google Scholar
  • Lutter, S. A., Currie, M. L., Mitz, L. B., Greenbaum, L. A.: Antibiotic resistance patterns in children hospitalized for urinary tract infections. Archives of Pediatrics & Adolescent Medicine 159(10) , 924–928 (2005).

    Greenbaum L. A. , 'Antibiotic resistance patterns in children hospitalized for urinary tract infections ' (2005 ) 159 Archives of Pediatrics & Adolescent Medicine : 924 -928.

    • Search Google Scholar
  • Cohen, A. L., Rivara, F. P., Davis, R., Christakis, D. A.: Compliance with guidelines for the medical care of first urinary tract infections in infants: a population-based study. Pediatrics 115(6) , 1474–1478 (2005).

    Christakis D. A. , 'Compliance with guidelines for the medical care of first urinary tract infections in infants: a population-based study ' (2005 ) 115 Pediatrics : 1474 -1478.

    • Search Google Scholar
  • Bradford, P. A.: Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14 , 933–951 (2001).

    Bradford P. A. , 'Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat ' (2001 ) 14 Clin. Microbiol. Rev. : 933 -951.

    • Search Google Scholar
  • Paterson, D. L., Bonomo, R. A.: Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18 , 657–686 (2005).

    Bonomo R. A. , 'Extended-spectrum beta-lactamases: a clinical update ' (2005 ) 18 Clin. Microbiol. Rev. : 657 -686.

    • Search Google Scholar
  • Pitout, J. D., Nordmann, P., Laupland, K. B., Poirel, L.: Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56 , 52–59 (2005).

    Poirel L. , 'Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community ' (2005 ) 56 J. Antimicrob. Chemother. : 52 -59.

    • Search Google Scholar
  • Ben-Ami, R., Schwaber, M. J., Navon-Venezia, S., Schwartz, D., Giladi, M., Chmelnitsky, I., Leavitt, A., Carmeli, Y.: Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin. Infect. Dis. 42 , 925–934 (2006).

    Carmeli Y. , 'Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital ' (2006 ) 42 Clin. Infect. Dis. : 925 -934.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
submission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2021 3 0 0
Jul 2021 2 0 0
Aug 2021 3 0 0
Sep 2021 5 0 0
Oct 2021 3 0 0
Nov 2021 4 0 0
Dec 2021 0 0 0